Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE.

Frederic MercierNaoual BakrinDavid L BartlettDiane GoereFrançois QuenetFrédéric DumontBruno HeydKarine AbboudChristelle MarolhoLaurent VilleneuveOlivier Glehennull nullnull null

Published in: Annals of surgical oncology (2018)

CRS and HIPEC may increases long-term survival in selected patients with peritoneal metastasis from rare ovarian tumors especially in mucinous, granulosa, or teratoma histological subtypes.

Keyphrases

minimally invasive
coronary artery bypass
low grade
big data
locally advanced
polycystic ovary syndrome
type diabetes
squamous cell carcinoma
machine learning
radiation therapy
coronary artery disease
insulin resistance
adipose tissue
metabolic syndrome
newly diagnosed
percutaneous coronary intervention